Annalena Bollinger

1.1k total citations
27 papers, 851 citations indexed

About

Annalena Bollinger is a scholar working on Immunology, Surgery and Physiology. According to data from OpenAlex, Annalena Bollinger has authored 27 papers receiving a total of 851 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 8 papers in Surgery and 4 papers in Physiology. Recurrent topics in Annalena Bollinger's work include Immune Cell Function and Interaction (5 papers), Peripheral Artery Disease Management (4 papers) and T-cell and B-cell Immunology (3 papers). Annalena Bollinger is often cited by papers focused on Immune Cell Function and Interaction (5 papers), Peripheral Artery Disease Management (4 papers) and T-cell and B-cell Immunology (3 papers). Annalena Bollinger collaborates with scholars based in Germany, United States and Switzerland. Annalena Bollinger's co-authors include Werner Solbach, Thomas Bollinger, Tanja Lange, Henrik Oster, Tamás Laskay, Ger van Zandbergen, Matthias Klinger, Silvia Bulfone‐Paus, Rajia Bahri and Zane Orinska and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Immunity.

In The Last Decade

Annalena Bollinger

25 papers receiving 828 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Annalena Bollinger Germany 11 341 167 164 148 144 27 851
Ronald McCarthy United States 10 423 1.2× 112 0.7× 89 0.5× 84 0.6× 170 1.2× 17 1.1k
S. P. James United States 26 697 2.0× 122 0.7× 32 0.2× 240 1.6× 445 3.1× 40 2.1k
Federico Mele Switzerland 11 1.0k 2.9× 84 0.5× 47 0.3× 94 0.6× 350 2.4× 18 1.7k
Wendy E. Walker United States 16 581 1.7× 258 1.5× 47 0.3× 360 2.4× 249 1.7× 29 1.3k
Ignatia Van den Veyver United States 14 83 0.2× 149 0.9× 153 0.9× 100 0.7× 223 1.5× 25 1.1k
Jeffrey D Fortman United States 17 247 0.7× 98 0.6× 128 0.8× 51 0.3× 68 0.5× 50 957
David W. Erikson United States 21 763 2.2× 46 0.3× 374 2.3× 50 0.3× 37 0.3× 51 1.7k
Esther I. Schwarz Switzerland 26 202 0.6× 860 5.1× 57 0.3× 622 4.2× 789 5.5× 141 2.6k
Shari E. Gelber United States 19 226 0.7× 106 0.6× 410 2.5× 22 0.1× 399 2.8× 38 1.7k
Sylvain Meuris Belgium 21 119 0.3× 84 0.5× 317 1.9× 40 0.3× 81 0.6× 66 1.3k

Countries citing papers authored by Annalena Bollinger

Since Specialization
Citations

This map shows the geographic impact of Annalena Bollinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annalena Bollinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annalena Bollinger more than expected).

Fields of papers citing papers by Annalena Bollinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annalena Bollinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annalena Bollinger. The network helps show where Annalena Bollinger may publish in the future.

Co-authorship network of co-authors of Annalena Bollinger

This figure shows the co-authorship network connecting the top 25 collaborators of Annalena Bollinger. A scholar is included among the top collaborators of Annalena Bollinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annalena Bollinger. Annalena Bollinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mupanomunda, Maria, Frederick A. Masoudi, Thomas A. Aloia, et al.. (2025). P-1447. Does Race or Social Vulnerability Play a Role in Antimicrobial Utilization for Admitted Patients? A Retrospective Analysis in a Large Healthcare System. Open Forum Infectious Diseases. 12(Supplement_1).
2.
Fakih, Mohamad G., Lisa Sturm, B. A. McKenzie, et al.. (2024). Optimizing and Sustaining Clinical Outcomes in 88 US Hospitals Post-Pandemic: A Quality Improvement Initiative. The Joint Commission Journal on Quality and Patient Safety. 51(2). 86–94.
3.
Fang, Xiangming, et al.. (2024). The economic burden of child marriage in Nigeria. Child Abuse & Neglect. 158. 107135–107135. 4 indexed citations
4.
Bollinger, Thomas, et al.. (2015). Transcription regulates HIF‐1α expression in CD4+ T cells. Immunology and Cell Biology. 94(1). 109–113. 9 indexed citations
5.
Bahri, Rajia, Annalena Bollinger, Thomas Bollinger, Zane Orinska, & Silvia Bulfone‐Paus. (2012). Ectonucleotidase CD38 Demarcates Regulatory, Memory-Like CD8+ T Cells with IFN-γ-Mediated Suppressor Activities. PLoS ONE. 7(9). e45234–e45234. 49 indexed citations
6.
Bollinger, Thomas, et al.. (2010). The influence of regulatory T cells and diurnal hormone rhythms on T helper cell activity. Immunology. 131(4). 488–500. 43 indexed citations
7.
Bollinger, Thomas, Annalena Bollinger, Henrik Oster, & Werner Solbach. (2010). Sleep, Immunity, and Circadian Clocks: A Mechanistic Model. Gerontology. 56(6). 574–580. 102 indexed citations
8.
Orinska, Zane, Niko Föger, Michael Huber, et al.. (2010). I787 provides signals for c-Kit receptor internalization and functionality that control mast cell survival and development. Blood. 116(15). 2665–2675. 11 indexed citations
9.
Stelekati, Erietta, Rajia Bahri, Orietta D’Orlando, et al.. (2009). Mast Cell-Mediated Antigen Presentation Regulates CD8+ T Cell Effector Functions. Immunity. 31(4). 665–676. 127 indexed citations
10.
Bollinger, Thomas, et al.. (2008). Sleep-dependent activity of T cells and regulatory T cells. Clinical & Experimental Immunology. 155(2). 231–238. 131 indexed citations
11.
Zandbergen, Ger van, Annalena Bollinger, S. Kamhawi, et al.. (2006). Leishmania disease development depends on the presence of apoptotic promastigotes in the virulent inoculum. Proceedings of the National Academy of Sciences. 103(37). 13837–13842. 163 indexed citations
12.
Zandbergen, Ger van, Jens Gieffers, H. Kothe, et al.. (2004). Chlamydia pneumoniae Multiply in Neutrophil Granulocytes and Delay Their Spontaneous Apoptosis. The Journal of Immunology. 172(3). 1768–1776. 126 indexed citations
13.
Bollinger, Annalena, et al.. (1997). Lack of a nocturnal rise in serum concentrations of melatonin as gilts attain puberty.. Journal of Animal Science. 75(7). 1885–1885. 12 indexed citations
14.
Uk, Franzeck, et al.. (1995). Effects of Subcutaneous Insulin-Like Growth Factor-I Infusion on Skin Microcirculation. PubMed. 15(1). 10–13. 3 indexed citations
15.
Meuli‐Simmen, Claudia, et al.. (1994). Long-Term Follow-Up after Finger and Upper Limb Replantation: Clinical, Angiological and Lymphographic Studies. Journal of Hand Surgery (European Volume). 19(1_suppl). 1–1. 2 indexed citations
16.
Boccalon, H., Annalena Bollinger, M. Catalano, et al.. (1993). Proposed training requirements for Medical Angiology fellows. International Angiology. 12(4). 323–325. 1 indexed citations
17.
Boccalon, H., Annalena Bollinger, M. Catalano, et al.. (1991). The case for the specialty of medical angiology. International Angiology. 10(4). 199–201. 5 indexed citations
18.
Widmer, L. K., et al.. (1986). [Development and growth of the Swiss Society of Angiology 1961-1986].. PubMed. 15(4). 279–301. 1 indexed citations
19.
Bollinger, Annalena, et al.. (1978). Die Kapillarmikroskopie als Untersuchungsmethode in der klinischen Angiologie*. DMW - Deutsche Medizinische Wochenschrift. 103(12). 523–527. 11 indexed citations
20.
Bollinger, Annalena, et al.. (1974). [Pseudohypertension in sclerosis of the media].. PubMed. 104(49). 1813–6. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ronald McCarthy Breakdown of academic impact, for papers by S. P. James Breakdown of academic impact, for papers by Federico Mele Breakdown of academic impact, for papers by Wendy E. Walker Breakdown of academic impact, for papers by Ignatia Van den Veyver Breakdown of academic impact, for papers by Jeffrey D Fortman Breakdown of academic impact, for papers by David W. Erikson Breakdown of academic impact, for papers by Esther I. Schwarz Breakdown of academic impact, for papers by Shari E. Gelber Breakdown of academic impact, for papers by Sylvain Meuris
Rankless by CCL
2026